Half of all working Americans report experiencing back pain symptoms every year – affecting more Americans than diabetes, heart disease and cancer combined. As the battle against the opioid crisis intensifies, doctors and patients now have a safer tool to manage chronic lower back pain – Erchonia’s FX 635 laser.
FDA Approved –
The FX 635 has been scientifically proven effective through a placebo-controlled, randomized, double-blind parallel group multi-center design study. Participants in the clinical trial experienced 58% pain reduction at their 2 month follow-up evaluations, progressively reducing low back pain over a 3-month interval to minimal levels (read more about the study).
How it Works –
The device does not come in contact with the patient’s skin or any other bodily tissue. Patients receive eight 20-minute procedure administrations across the lower back region across a four-week period: two procedures per week, each procedure three to four days apart. As needed, patients can use Tylenol and the device's safety is supported through study results.
